Table 1: Patients’ demographics and clinical characteristics.
|
Total N = 96,870 |
With Post-Discharge VTE N = 880 (0.9%) |
Without Post-Discharge VTE N = 95,990 (99.1%) |
P-Value |
Variables |
N (%) |
N (%) |
N (%) |
|
Age* |
n = 75,940 |
n = 694 |
n = 75,246 |
|
18 - 75 |
28,888 (38.0%) |
237 (34.1%) |
28,651 (38.1%) |
0.034 |
≥ 75 |
47,052 (62.0%) |
457 (65.9%) |
46,596 (61.9%) |
|
Gender* |
n = 96,869 |
n = 880 |
n = 95989 |
|
Male |
29,901 (30.9%) |
264 (30.0%) |
29,637 (30.9%) |
0.607 |
Female |
66,968 (69.1%) |
616 (70.0%) |
66,352 (69.1%) |
|
Body mass index* |
n = 90,503 |
n = 749 |
n = 89,654 |
|
<18.5 |
9,930 (11.0%) |
58 (6.8%) |
9,872 (11.0%) |
< 0.001 |
18.5-24.9 |
42,043 (46.5%) |
266 (43.1%) |
41,677 (46.5%) |
|
25-29.9 |
24,373 (26.9%) |
255 (30.0%) |
24,118 (26.9%) |
|
≥ 30 |
14,157 (15.6%) |
170 (20.0%) |
13,987 (15.6%) |
|
Functional status* |
n = 96,047 |
n = 876 |
n = 95,171 |
|
Independent |
75,134 (78.2%) |
712 (81.3%) |
74,422 (78.2%) |
0.03 |
Dependent |
20,913 (21.8%) |
164 (18.7%) |
20,749 (21.8%) |
|
5i-mFI* |
n = 96,047 |
n = 876 |
n = 95,171 |
|
0 |
21,834 (22.7%) |
190 (21.7%) |
21,644 (22.7%) |
0.015 |
0.2 |
41,546 (43.3%) |
406 (46.3%) |
41,140 (43.2%) |
|
0.4 |
25,438 (26.5%) |
197 (22.5%) |
25,241 (26.5%) |
|
0.6 |
6,245 (6.5%) |
73 (8.3%) |
6,172 (6.5%) |
|
≥ 0.8 |
984 (1.0%) |
10 (1.1%) |
974 (1.0%) |
|
Diabetes Mellites |
17,868 (18.4%) |
160 (18.2%) |
17,708 (18.4%) |
0.858 |
Smoker |
12,127 (12.5%) |
88 (10.0%) |
12,039 (12.5%) |
0.026 |
CHF |
3,469 (3.5%) |
30 (3.4%) |
3,439 (3.6%) |
0.845 |
Hypertension |
63,284 (65.3%) |
599 (68.1%) |
62,685 (65.3%) |
0.088 |
COPD |
10,514 (10.9%) |
111 (12.6%) |
10,403 (10.8%) |
0.089 |
Dyspnea on exertion |
7,506 (7.7%) |
89 (9.9%) |
7,417 (7.7%) |
0.02 |
Anemia* |
56,736/91,960 (61.1%) |
508/845 (60.1%) |
56,228/91960 (61.1%) |
0.547 |
Bleeding disorders |
15,129 (15.6%) |
129 (14.7%) |
15,000 (15.6%) |
0.454 |
Preoperative dialysis |
1,749 (1.8%) |
8 (0.9%) |
1,741 (1.8%) |
0.049 |
Disseminated cancer |
2,888 (3.0%) |
57 (6.5%) |
2,831 (2.9%) |
< 0.001 |
10% body weight loss |
1,817 (1.9%) |
19 (2.2%) |
1798 (1.9%) |
0.541 |
Chronic Steroid Use |
5,173 (5.3%) |
68 (7.7) |
5,105 (5.3%) |
0.002 |
* Indicates certain cases had missing information for the study variable. List-wise deletion was performed as necessary